Position in SRPT
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,390,753
-$28,050 QoQ
Shares Held
244,338
+20.3% QoQ
Ownership
0.231%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#55
of 323 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 48%
Shared 0%
None 52%
Common Shares in SRPT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,414,750,230 across 329 Biotechnology names. SRPT ranks #58 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
396,380 | $196,893,837 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
157,794 | $98,390,870 | |
| 3 | MRNA |
Moderna, Inc.
|
809,853 | $56,714,005 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
165,579 | $49,844,246 | |
| 5 | INCY |
Incyte Corp
|
428,533 | $48,578,500 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
226,008 | $42,326,778 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
1,178,789 | $41,717,342 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
163,018 | $39,282,447 |
All Filings in SRPT
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,390,753 | 244,338 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $4,418,803 | 203,070 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $4,091,124 | 190,108 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,438,172 | 178,421 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $4,571,069 | 267,314 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $16,927,872 | 265,244 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $32,577,973 | 267,933 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $33,829,204 | 270,872 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $42,808,678 | 270,941 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $14,240,470 | 109,999 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $11,424,254 | 118,472 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $14,891,998 | 122,851 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $14,184,676 | 123,862 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $14,776,065 | 107,205 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $13,065,292 | 100,828 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $10,374,510 | 93,853 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $6,612,896 | 88,219 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $6,114,608 | 78,272 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $7,337,634 | 81,484 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $6,821,972 | 73,767 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $5,771,495 | 74,241 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $5,838,829 | 78,342 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $14,334,458 | 84,078 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $12,063,779 | 85,906 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $14,258,234 | 88,925 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $7,270,569 | 74,326 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||